G'day, just a little read on the enormous unmet need for an effective Dengue medicine. The article discusses the ongoing attempts to exploit the protease-inhibitors used in existing HCV treatments for use against Dengue, an expected billion dollar market.
BIT225 is in preclinical studies to determine efficacy against Dengue.
The link is as follows:
http://www.bloomberg.com/news/2010-10-26/break-bone-fever-draws-roche-drug-as-dengue-virus-hits-riviera.html
Cheers
G'day, just a little read on the enormous unmet need for an...
-
- There are more pages in this discussion • 74 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.0¢ |
Change
-0.001(4.76%) |
Mkt cap ! $18.04M | |||
| Open | High | Low | Value | Volume |
| 2.1¢ | 2.1¢ | 2.0¢ | $12.00K | 600.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 972631 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 199783 | 1 |
View Market Depth
| Last trade - 14.33pm 01/11/2024 (20 minute delay) ? |
| BIT (ASX) Chart |